Management of progressive multifocal leukoencephalopathy associated with natalizumab - possibilities and responsibility

被引：0
|
作者：
Holmoy, T. [1 ]
Hestvik, A. L. K.
Vartdal, F.
机构：
[1] Univ Hosp, Rikshosp, Inst Immunol, Oslo, Norway
[2] Ullevaal Univ Hosp, Dept Neurol, Oslo, Norway
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷 / 08期
关键词：
D O I：
10.1111/j.1468-1331.2006.01555.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E2 / E2
页数：1
相关论文
共 50 条
  • [31] Unusual natalizumab-associated progressive multifocal leukoencephalopathy starting in the brainstem
    Joachim Havla
    Reinhard Hohlfeld
    Tania Kümpfel
    Journal of Neurology, 2014, 261 : 232 - 234
  • [32] Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy
    Hoepner, Robert
    Kolb, Eva M.
    Dahlhaus, Stefanie
    Hellwig, Kerstin
    Adams, Ortwin
    Kleiter, Ingo
    Salmen, Anke
    Schneider, Ruth
    Lukas, Carsten
    Chan, Andrew
    Berger, Joseph R.
    Gold, Ralf
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (06) : 830 - 835
  • [33] A Case of Natalizumab-associated Progressive Multifocal Leukoencephalopathy—Role for Advanced MRI?
    M. Berghoff
    B. Dassinger
    J. Iwinska-Zelder
    M. Giraldo
    S. Bilgin
    M. Kaps
    E. R. Gizewski
    Clinical Neuroradiology, 2014, 24 : 173 - 176
  • [34] Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy
    Classen, G.
    Classen, C.
    Bernasconi, C.
    Brandt, C.
    Gold, R.
    Chan, A.
    Hoepner, R.
    JOURNAL OF NEUROVIROLOGY, 2019, 25 (01) : 133 - 136
  • [35] Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy
    Yousry, Tarek A.
    Pelletier, Daniel
    Cadavid, Diego
    Gass, Achim
    Richert, Nancy D.
    Radue, Ernst-Wilhelm
    Filippi, Massimo
    ANNALS OF NEUROLOGY, 2012, 72 (05) : 779 - 787
  • [36] Natalizumab-associated progressive multifocal leukoencephalopathy is not preceded by elevated drug concentrations
    van Kempen, Zoe L. E.
    Leurs, Cyra E.
    Vennegoor, Anke
    Wattjes, Mike P.
    Rispens, Theo
    Uitdehaag, Bernard M. J.
    Killestein, Joep
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (07) : 995 - 999
  • [37] Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy
    Tuan Dong-Si
    Sarah Gheuens
    Amy Gangadharan
    Made Wenten
    Jeffrey Philip
    James McIninch
    Shoibal Datta
    Nancy Richert
    Carmen Bozic
    Gary Bloomgren
    Sandra Richman
    Thomas Weber
    David B. Clifford
    Journal of NeuroVirology, 2015, 21 : 637 - 644
  • [38] Overview of Clinical Outcomes in Cases of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
    Gold, Ralf
    Foley, John
    Vermersch, Patrick
    Kappos, Ludwig
    Olsson, Tomas
    Cadavid, Diego
    Bozic, Carmen
    Richman, Sandra
    NEUROLOGY, 2011, 76 (09) : A636 - A636
  • [39] New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML) Associated With Natalizumab (Tysabri)
    不详
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (08) : II - II
  • [40] Re-evaluating the incidence of natalizumab-associated progressive multifocal leukoencephalopathy
    Borchardt, Julian
    Berger, Joseph R.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 8 : 145 - 150
12345